Abstract:OBJECTIVE:The purpose of this study is to evaluate quantitative analysis of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of renal tumor histotypes.MATERIALS AND METHODS:Between January 2010 and December 2013, 106 clear cell renal cell carcinomas (RCCs) (mean [± SD] diameter, 3.7 ± 1.8 cm), 34 angiomyolipomas (mean diameter, 4.1 ± 1.4 cm), 25 papillary RCCs (mean diameter, 3.5 ± 1.1 cm), and 28 chromophobe RCCs (mean diameter, 2.9 ± 0.9 cm) underwent CEUS quantitative analysis. The dynamic vascular pattern was analyzed with the Fisher exact chi-square test, and rise time, time to peak (TTP), and tumor-to-cortex enhancement ratio were analyzed with the independent-sample t test.RESULTS:Dynamic vascular pattern types I and III (hyperenhancement) were more common among clear cell RCCs, whereas type II (hypoenhancement) was more common among angiomyolipomas, papillary RCCs, and chromophobe RCCs. Irrespective of dynamic vascular pattern class, the rise time and TTP were the shortest in clear cell RCCs and were equal in angiomyolipomas, papillary, and chromophobe RCCs. The tumor-to-cortex enhancement ratio was the highest in clear cell RCCs, was second highest in angiomyolipomas, and was lowest but equal in papillary and chromophobe RCCs. Clear cell RCCs and angiomyolipomas accounted for the majority of the hyperenhancing group. The tumor-to-cortex enhancement ratio of clear cell RCCs was higher than that of angiomyolipomas. With tumor-to-cortex enhancement ratio greater than 146.0% as the cutoff to differentiate clear cell RCC from angiomyolipoma in the hyperenhanced group, the sensitivity and specificity were each 71.4%. In the hypoenhanced group, the tumor-to-cortex enhancement ratio was the same in clear cell RCCs and angiomyolipomas but was higher in papillary and chromophobe RCCs. With tumor-to-cortex enhancement ratio greater than 54.2% as the cutoff point to differentiate clear cell RCCs from papillary and chromophobe RCCs, the sensitivity and specificity were 95.5% and 94.8%, respectively, whereas with a tumor-to-cortex enhancement ratio greater than 57.4% as the cutoff point to differentiate angiomyolipomas from papillary and chromophobe RCCs, the sensitivity and specificity were 90.0% and 96.4%, respectively.CONCLUSION:Quantitative analysis of CEUS can show quantification of enhancement features of different renal tumor histotypes and may be helpful in their differential diagnosis.

Associations Between Tumor Grade, Contrast-Enhanced Ultrasound Features, and Microvascular Density in Patients with Clear Cell Renal Cell Carcinoma: a Retrospective Study

Evaluating value of spiral CT in enhanced-degree of renal clear cell carcinoma

Correlation between pathological grade and ultrasonographic features of clear cell renal carcinoma

Contrast-enhanced Ultrasound for Detection and Diagnosis of Renal Clear Cell Carcinoma.

Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound

Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound

Parametric Imaging for Characterizing Clear Cell Renal Cell Carcinoma with Contrast-Enhanced Ultrasound

Pilot Study of Three-Dimensional Contrast-Enhanced Ultrasound in Vascular Patterns of Renal Tumors

Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.

Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma

Grading Clear Cell Renal Cell Carcinoma Grade Using Diffusion Relaxation Correlated MR Spectroscopic Imaging

Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study

The Value of Contrast-Enhanced Ultrasound (CEUS) in Detecting Minute Renal Cell Carcinoma.

Identification of ISUP grade of clear cell renal cell carcinoma by radiomics on multi-phase CT images

Characteristics of contrast‐enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas ≤4 cm: A meta‐analysis

Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT

Characteristics Analysis of Clear Cell Renal Cell Carcinoma by Contrast-Enhanced Ultrasound

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma

Differentiation of Subtypes of Renal Cell Carcinoma with Contrast-Enhanced Ultrasonography

A Diagnostic Test of Three-Dimensional Magnetic Resonance Elastography Imaging for Preoperative Prediction of Microvascular Invasion in Patients with T1 Stage Clear Cell Renal Carcinoma